The use of artificial intelligence to support drug discovery and design efforts is a rapidly expanding field, with new players looking to streamline AI’s role in drug discovery and translation. One such player is Montreal-headquartered Valence Discovery, which is looking to capture the clinical insights of ‘few-shot learning’...
